Meites J
Clin Endocrinol (Oxf). 1977;6 Suppl:9S-18S. doi: 10.1111/j.1365-2265.1977.tb03334.x.
Hypothalamic regulation of prolactin secretion in animals (mammals) and man appears to be similar, and no significant differences have yet been demonstrated. The hypothalamus contains neurotransmitters and polypeptides that can either inhibit or stimulate prolactin release, although the predominant influence under basal conditions is to inhibit prolactin release. Thus pituitary stalk section or placement of lesions in the basal tuberal region of the hypothalamus results in increased prolactin release and sometimes in initiation of lactation. Among agents in the hypothalamus that can inhibit prolactin release, the most important appear to be an as yet unidentified polypeptide prolactin release inhibiting factor (PIF) and dopamine. There is some evidence that dopamine may account for most, if not all, of the prolactin release inhibiting activity of the hypothalamus. Agents that increase dopamine activity, i.e. L-dopa, monoamine oxidase inhibitors, etc., depress prolactin release. Acetylcholine also can inhibit prolactin release, but it appears to act via the catecholamines. Of the agents in the hypothalamus that stimulate prolactin release, the most important appear to be an as yet uncharacterized polypeptide prolactin releasing factor (PRF), thyrotropin releasing hormone (TRH) and serotonin. TRH is as effective in releasing prolactin as in releasing TSH, but under most physiological states, TSH and prolactin release do not occur together. Serotonin and its precursors, tryptophan and 5-hydroxytryptophan, are powerful releasors of prolactin and have been shown to be involved in some physiological states in which prolactin is released, i.e. during suckling, stress, etc. Other agents in the hypothalamus that can stimulate prolactin release include GABA and some prostaglandins, but these have not yet been shown to be involved in physiological control of prolactin secretion. Exteroceptive stimuli that alter prolactin release act through the CNS and hypothalamus, but some hormones and drugs also can act directly on the pituitary to promote or depress prolactin release.
下丘脑对动物(哺乳动物)和人类催乳素分泌的调节似乎是相似的,尚未发现显著差异。下丘脑含有能抑制或刺激催乳素释放的神经递质和多肽,尽管在基础条件下主要影响是抑制催乳素释放。因此,垂体柄切断或在下丘脑基部结节区放置损伤会导致催乳素释放增加,有时还会引发泌乳。在下丘脑中能抑制催乳素释放的物质中,最重要的似乎是一种尚未确定的多肽催乳素释放抑制因子(PIF)和多巴胺。有一些证据表明,多巴胺可能占下丘脑催乳素释放抑制活性的大部分(如果不是全部的话)。增加多巴胺活性的物质,即左旋多巴、单胺氧化酶抑制剂等,会抑制催乳素释放。乙酰胆碱也能抑制催乳素释放,但它似乎是通过儿茶酚胺起作用。在下丘脑中能刺激催乳素释放的物质中,最重要的似乎是一种尚未明确的多肽催乳素释放因子(PRF)、促甲状腺激素释放激素(TRH)和5-羟色胺。TRH释放催乳素的效果与释放促甲状腺激素一样,但在大多数生理状态下,促甲状腺激素和催乳素的释放不会同时发生。5-羟色胺及其前体色氨酸和5-羟色氨酸是催乳素的强力释放剂,已被证明参与一些催乳素释放的生理状态,如哺乳、应激等。下丘脑中其他能刺激催乳素释放的物质包括γ-氨基丁酸和一些前列腺素,但尚未证明它们参与催乳素分泌的生理控制。改变催乳素释放的外感受性刺激通过中枢神经系统和下丘脑起作用,但一些激素和药物也能直接作用于垂体,促进或抑制催乳素释放。